Nephrocare Health shares pop on debut, IPO sees big buzz
Nephrocare Health Services hit the stock market with a bang, opening at nearly 7% above its IPO price of ₹460.
Shares started trading at ₹490 on NSE and ₹491.70 on BSE, after strong gray market interest hinted at a premium.
How much did they raise?
Nephrocare's IPO brought in over ₹871 crore—₹353 crore from new shares and the rest from existing shareholders selling their stake.
The price range was set between ₹438-₹460 per share, and you needed to buy at least 32 shares to get in.
Why all the hype?
Investors were clearly interested: the IPO was subscribed 14.08 times overall.
Big institutions scrambled for shares (about 27 times demand), but even retail investors showed up in force, with more than 4.5 lakh applications.
What does Nephrocare actually do?
Based in Hyderabad, Nephrocare runs over 500 dialysis clinics across India and a few abroad.
They offer dialysis both in clinics and at home, plus diagnostics and an in-house pharmacy.
Money from the IPO will help them open more clinics, pay off debt, and boost growth plans.